Status | Study |
Active, not recruiting |
Study Name: Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor Condition: Sarcoma Desmoplastic Small Round Cell Tumor (DSRCT) Date: 2010-08-25 Interventions: Drug: irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylator |
Completed |
Study Name: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Condition: Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Adult Date: 2010-06-29 Interventions: Drug: Gamma-Secretase Inhibitor RO4929097 |
Suspended |
Study Name: Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease Condition: Sarcoma Adenocarcinoma Carcinoma Date: 2010-05-16 Interventions: Drug: Ascorbic acid (vitamin C) Intravenous administration of up to 1.5gm/kg of ascorbic acid, twice wee |
Recruiting |
Study Name: Intraperitoneal Radioimmunotherapy With 131I-8H9 for Patients With Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneum Condition: Peritoneal Cancer Date: 2010-04-06 Interventions: Biological: 131 I-8H9 Patients will be administered therapeutic dose of IP 131I-8H9 per the dose escalat |
Recruiting |
Study Name: Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Condition: Adult Rhabdomyosarcoma Childhood Desmoplastic Small Round Cell Tumor Date: 2009-06-11 Interventions: Other: biologic sample preservation procedure |
Completed |
Study Name: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Condition: Adult Angiosarcoma Adult Desmoplastic Small Round Cell Tumor Date: 2008-07-19 Interventions: Biological: Cixutumumab Given |
Completed |
Study Name: QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors Condition: Askin's Tumors Desmoplastic Small Round Cell Tumors Date: 2007-11-21 Interventions: Drug: AMG 479 AMG 479 is a fully human monoclonal antibody (IgG1) against the insulin-like growth factor |
Active, not recruiting |
Study Name: Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Condition: Brain and Central Nervous System Tumors Intraocular Melanoma Date: 2007-03-07 Interventions: Genetic: DNA analysis Other: immunologic t |
Completed |
Study Name: Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer Condition: Peritoneal Neoplasms Retroperitoneal Neoplasms Gastrointes Date: 2007-02-15 Interventions: Drug: CHPP of Cisplatin Starti |
Completed |
Study Name: Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors Condition: Refractory Desmoplastic Small Round Cell Tumors Date: 2007-01-02 Interventions: Drug: Imatinib mesilate Other Name: STI571 |